Advertisement

Chemoprevention of Skin Cancer with Photodynamic Therapy

  • Robert BissonnetteEmail author
Chapter

Abstract

Photodynamic therapy with ALA or MAL is safe and effective for the treatment and prevention of actinic keratoses. This modality has several advantages over 5-FU and imiquimod and its use should expand in the coming years with the wider availability of both photosensitizers.

Keywords

Skin Cancer Basal Cell Carcinoma Light Exposure Actinic Keratose Skin Cancer Prevention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hauschild A, Stockfleth E, Popp G, et al. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol. 2009;160:1066–74.PubMedCrossRefGoogle Scholar
  2. 2.
    Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis – an update. Br J Dermatol. 2007;157 Suppl 2:18–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140:33–40.PubMedCrossRefGoogle Scholar
  4. 4.
    Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis–a systematic review of randomized controlled trials. Int J Dermatol. 2009;48:453–63.PubMedCrossRefGoogle Scholar
  5. 5.
    Pearlman DL. Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses. J Am Acad Dermatol. 1991;25:665–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157 Suppl 2:34–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaminaka C, Yamamoto Y, Yonei N, Kishioka A, Kondo T, Furukawa F. Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations. J Am Acad Dermatol. 2009;60:615–25.PubMedCrossRefGoogle Scholar
  8. 8.
    Sharfaei S, Juzenas P, Moan J, Bissonnette R. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res. 2002;294:237–42.PubMedGoogle Scholar
  9. 9.
    Korbelik M. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med. 2006;38:500–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Kabingu E, Oseroff AR, Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res. 2009;15:4460–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol. 1997;66:493–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Liu Y, Viau G, Bissonnette R. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice. J Cutan Med Surg. 2004;8:131–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Caty V, Liu Y, Viau G, Bissonnette R. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice. Br J Dermatol. 2006;154:740–2.PubMedGoogle Scholar
  14. 14.
    Bissonette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol. 2004;3:S26–31.PubMedGoogle Scholar
  15. 15.
    Wennberg AM, Stenquist B, Stockfleth E, et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation. 2008;86:423–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol. 2006;86:25–8.PubMedGoogle Scholar
  17. 17.
    de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol. 2006;126:569–74.PubMedCrossRefGoogle Scholar
  18. 18.
    Apalla Z, Sotiriou E, Chovarda E, Lefaki I, Devliotou-Panagiotidou D, Ioannides D. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol. 2010;162(1):171–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. J Drugs Dermatol. 2005;4:161–3.PubMedGoogle Scholar
  20. 20.
    Shaffelburg M. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream. J Drugs Dermatol. 2009;8:35–9.PubMedGoogle Scholar
  21. 21.
    Ishida N, Watanabe D, Akita Y, et al. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy. Clin Exp Dermatol. 2009;34:385–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Wiegell SR, Haedersdal M, Wulf HC. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol. 2009;89:145–9.PubMedGoogle Scholar
  23. 23.
    Paoli J, Halldin C, Ericson MB, Wennberg AM. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol. 2008;33:559–64.PubMedCrossRefGoogle Scholar
  24. 24.
    Bissonnette R, Nigen S, Bolduc C, Mery S, Nocera T. Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid. Dermatol Surg. 2008;34:1469–76.PubMedCrossRefGoogle Scholar
  25. 25.
    Oseroff AR, Shieh S, Frawley NP, et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol. 2005;141:60–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Innovaderm ResearchMontrealCanada

Personalised recommendations